Furthermore, to further elucidate the impact of PD‐L1 antibody on the therapeutic efficacy of the combined treatment involving LV‐HIC1 or LV‐shHIC1, MFC‐challenged subcutaneous GC model in 615‐line mice (immunocompromised) was constructed. The gene discussed is CD274; the disease is gastric cancer.